Syngenta and Bayer reach agreement on patent disputes
Syngenta AG and Bayer AG announced that they have reached an agreement on their intellectual property dis-putes in neonicotinoid chemistry which are the subject of various proceedings in the United States, Europe and Ja-pan. Under the terms of the agreement, Syngenta will pay Bayer $120 million in return for full access to crop pro-tection and related markets worldwide.
“Thiamethoxam’s worldwide potential can now be fully realized particularly in the major agricultural markets. We are pleased to have resolved these complex issues and to have reached this agreement with Bayer,” said John Atkin, chief operating officer of Syngenta Crop Protection. Syngenta’s thiamethoxam brands include ACTARA®, CRUISER®, HELIX®, PLATINUM® and CENTRIC®.
“Reaching an agreement on this lengthy patent dispute was not easy but we are convinced that this is in the best interest of our customers,” said Jochen Wulff, president and CEO of Bayer’s crop protection division. Bayer will continue to serve all markets with its imidacloprid based insecticides CONFIDOR, ADMIRE and GAUCHO as well as with the recently launched new-generation chloronicotinyl insecticide CALYPSO.